Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11424039rdf:typepubmed:Citationlld:pubmed
pubmed-article:11424039lifeskim:mentionsumls-concept:C0085584lld:lifeskim
pubmed-article:11424039lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:11424039lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:11424039lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:11424039pubmed:issue9lld:pubmed
pubmed-article:11424039pubmed:dateCreated2001-6-25lld:pubmed
pubmed-article:11424039pubmed:abstractTextThe severe epileptic syndromes of infancy are dependent on age, symptomatic or cryptogenic aetiology and are drug-resistant so that overall prognosis control of epilepsy and adequate cognition is poor so that some authors consider it to be catastrophic. All may be identified and differentiated on electroclinical criteria.lld:pubmed
pubmed-article:11424039pubmed:languagespalld:pubmed
pubmed-article:11424039pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11424039pubmed:citationSubsetIMlld:pubmed
pubmed-article:11424039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11424039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11424039pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11424039pubmed:statusMEDLINElld:pubmed
pubmed-article:11424039pubmed:issn0210-0010lld:pubmed
pubmed-article:11424039pubmed:authorpubmed-author:Campos-Castel...lld:pubmed
pubmed-article:11424039pubmed:issnTypePrintlld:pubmed
pubmed-article:11424039pubmed:volume32lld:pubmed
pubmed-article:11424039pubmed:ownerNLMlld:pubmed
pubmed-article:11424039pubmed:authorsCompleteYlld:pubmed
pubmed-article:11424039pubmed:pagination860-6lld:pubmed
pubmed-article:11424039pubmed:dateRevised2009-5-28lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:meshHeadingpubmed-meshheading:11424039...lld:pubmed
pubmed-article:11424039pubmed:articleTitle[Therapeutic strategy in severe encephalopathies].lld:pubmed
pubmed-article:11424039pubmed:affiliationServicio de Neuropediatría.; Hospital Clínico Universitario San Carlos, Madrid, 28040, España. jcampos@hcsc.insalud.eslld:pubmed
pubmed-article:11424039pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11424039pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11424039pubmed:publicationTypeReviewlld:pubmed